Clinical trial
A Comparative Study of the Safety, Tolerability, and Efficacy of Cefdinir and Cephalexin for the Treatment of Subjects With Mild to Moderate Uncomplicated Skin and Skin Structure Infections
NCT00234949 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative Study of the Safety, Tolerability, and Efficacy of Cefdinir and Cephalexin for the Treatment of Subjects With Mild to Moderate Uncomplicated Skin and Skin Structure Infections
- Lead sponsor
- Abbott
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- Not reported
- Enrollment
- 380
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
mild to moderate uncomplicated skin and skin structure infections